Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 18, 2015 | San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy | The immunotherapy biotech just raised $4.3 million, according to a regulatory filing. The research comes from Torrey Pines Institute for Molecular Studies. Its lead program, the oral drug GRI-0621, is in the midst of early clinical studies ... |
| San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy | San Diego biotech Glycoregimmune is working on a way to inhibit the natural killer T cells that exacerbate the inflammatory response and hepatic injury that stems from liver disease. Natural killer T cells are a sort of heterogenous variety... |
Reviews 0
FAQ about Torrey Pines Institute: Non
When was Torrey Pines Institute: Non founded?
Torrey Pines Institute: Non was founded in 1988.
What has the press written about Torrey Pines Institute: Non?
Parsers VC has collected 3 articles mentioning Torrey Pines Institute: Non, among them “San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy” (Apr 18, 2015) and “San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy”.
Is Torrey Pines Institute: Non still active?
Torrey Pines Institute: Non is probably closed: its latest activity on Parsers VC dates from Oct 26, 2025.